US 7189706
C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them
granted A61PA61P17/02A61P25/00
Quick answer
US patent 7189706 (C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them) held by CAN-FITE BIOPHARMA LTD. expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CAN-FITE BIOPHARMA LTD.
- Grant date
- Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P17/02, A61P25/00, A61P25/04, A61P25/18